These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22815335)

  • 1. Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center.
    Baudry C; Coste J; Bou Khalil R; Silvera S; Guignat L; Guibourdenche J; Abbas H; Legmann P; Bertagna X; Bertherat J
    Eur J Endocrinol; 2012 Oct; 167(4):473-81. PubMed ID: 22815335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian macrocysts and gonadotrope-ovarian axis disruption in premenopausal women receiving mitotane for adrenocortical carcinoma or Cushing's disease.
    Salenave S; Bernard V; Do Cao C; Guignat L; Bachelot A; Leboulleux S; Droumaguet C; Bry-Gauillard H; Pierre P; Crinière L; Santulli P; Touraine P; Chanson P; Schlumberger M; Maiter D; Baudin E; Young J
    Eur J Endocrinol; 2015 Feb; 172(2):141-9. PubMed ID: 25411236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
    Lau D; Rutledge C; Aghi MK
    Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
    Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The long-term therapy of hypothalamic-hypophyseal Cushing's syndrome with mitotane (o,p'-DDD)].
    Knappe G; Gerl H; Ventz M; Rohde W
    Dtsch Med Wochenschr; 1997 Jul; 122(28-29):882-6. PubMed ID: 9264918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of primary empty sella syndrome on pituitary surgery for Cushing's disease.
    Mehta GU; Bakhtian KD; Oldfield EH
    J Neurosurg; 2014 Sep; 121(3):518-26. PubMed ID: 24857241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role for retinoic acid in patients with Cushing's disease.
    Pecori Giraldi F; Ambrogio AG; Andrioli M; Sanguin F; Karamouzis I; Corsello SM; Scaroni C; Arvat E; Pontecorvi A; Cavagnini F
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3577-83. PubMed ID: 22851491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of repeated transsphenoidal surgery in Cushing's disease. Long-term follow-up.
    Valderrábano P; Aller J; García-Valdecasas L; García-Uría J; Martín L; Palacios N; Estrada J
    Endocrinol Nutr; 2014 Apr; 61(4):176-83. PubMed ID: 24355549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease.
    Castinetti F; Morange I; Jaquet P; Conte-Devolx B; Brue T
    Eur J Endocrinol; 2008 Jan; 158(1):91-9. PubMed ID: 18166822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique: a good therapeutic option for recurrent or persistent Cushing's disease (CD).
    Wagenmakers MA; Netea-Maier RT; van Lindert EJ; Timmers HJ; Grotenhuis JA; Hermus AR
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):274-80. PubMed ID: 18616702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
    Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
    Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cushing's disease.
    Tritos NA; Biller BM
    Handb Clin Neurol; 2014; 124():221-34. PubMed ID: 25248590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
    Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER
    Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment of Cushing's disease.
    Feelders RA; Hofland LJ
    J Clin Endocrinol Metab; 2013 Feb; 98(2):425-38. PubMed ID: 23345100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery.
    Patil CG; Prevedello DM; Lad SP; Vance ML; Thorner MO; Katznelson L; Laws ER
    J Clin Endocrinol Metab; 2008 Feb; 93(2):358-62. PubMed ID: 18056770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.
    Ramm-Pettersen J; Halvorsen H; Evang JA; Rønning P; Hol PK; Bollerslev J; Berg-Johnsen J; Helseth E
    BMC Endocr Disord; 2015 Oct; 15():62. PubMed ID: 26499317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection.
    Terzolo M; Baudin AE; Ardito A; Kroiss M; Leboulleux S; Daffara F; Perotti P; Feelders RA; deVries JH; Zaggia B; De Francia S; Volante M; Haak HR; Allolio B; Al Ghuzlan A; Fassnacht M; Berruti A
    Eur J Endocrinol; 2013 Sep; 169(3):263-70. PubMed ID: 23704714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral Adrenalectomy as a First-Line Treatment of Cushing's Syndrome in Patients With Primary Bilateral Macronodular Adrenal Hyperplasia.
    Debillon E; Velayoudom-Cephise FL; Salenave S; Caron P; Chaffanjon P; Wagner T; Massoutier M; Lambert B; Benoit M; Young J; Tabarin A; Chabre O
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4417-24. PubMed ID: 26451908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment patterns in Cushing's disease patients in two large United States nationwide databases: application of a novel, graphical methodology.
    Broder MS; Neary MP; Chang E; Cherepanov D; Sun GH; Ludlam WH
    Pituitary; 2015 Aug; 18(4):474-9. PubMed ID: 25246076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease.
    Amlashi FG; Swearingen B; Faje AT; Nachtigall LB; Miller KK; Klibanski A; Biller BM; Tritos NA
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3770-7. PubMed ID: 26196950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.